Cardinal Health’s Rebecca McGrath and Jerrica Mathis named 2023 The Hill’s Top Lobbyists

Rebecca McGrath, Cardinal Health’s SVP of Government Relations and Public Policy, and Jerrica Mathis, VP of Federal Government Relations and Public Policy, have been named to The Hill’s list of 2023 top lobbyists. The Hill is a Washington, D.C.-based newspaper and…

Read MoreCardinal Health’s Rebecca McGrath and Jerrica Mathis named 2023 The Hill’s Top Lobbyists

Cardinal Health Issues Medical Device Recall for Nurse Assist Products Contained Within Kits/Trays

In direct response to the Nurse Assist, LLC voluntary product recall (which included products supplied to Cardinal Health used in Covidien and Cardinal Health™ brand kits and trays), Cardinal Health issued a medical device recall on December 5, 2023, for its Covidien…

Read MoreCardinal Health Issues Medical Device Recall for Nurse Assist Products Contained Within Kits/Trays

World Courier to Expand Storage Capacity and Cold Chain Capabilities With Three New Transport Stations in the United States

 World Courier, a global specialty logistics provider and a part of Cencora (formerly AmerisourceBergen), will open transport stations in three new markets in the United States, expanding its presence and capacity to deliver specialized logistics support as the specialty pharmaceutical market continues…

Read MoreWorld Courier to Expand Storage Capacity and Cold Chain Capabilities With Three New Transport Stations in the United States

Burjeel Holdings Oncology Conference Celebrates 10 Years, Focusing on Equitable Solutions for Cancer Care

The 10th anniversary of the Burjeel Holdings Oncology Conference, held in partnership with Foreign Policy, brought together leading global experts to tackle the complex challenges of cancer care, emphasizing the need for multi-stakeholder collaboration. With cancer claiming millions of lives…

Read MoreBurjeel Holdings Oncology Conference Celebrates 10 Years, Focusing on Equitable Solutions for Cancer Care

QuidelOrtho Receives 510(K) Clearance for Savanna® Multiplex Molecular Platform and Savanna® HSV 1+2/VZV PCR Assay

 Quidel Corporation (NASDAQ: QDEL), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine, has received 510(K) clearance from the U.S. Food and Drug Administration for its innovative Savanna PCR platform and…

Read MoreQuidelOrtho Receives 510(K) Clearance for Savanna® Multiplex Molecular Platform and Savanna® HSV 1+2/VZV PCR Assay

DaVita Giving Foundation Invests $1 Million in Western Governors University to Support Nursing Students

 The DaVita Giving Foundation has awarded Western Governors University’s (WGU) Michael O. Leavitt School of Health (LSH) a $1 million grant over the next three years to support more than 1,500 nursing students in Start Early, a program co-created by DaVita Inc. and WGU to help increase…

Read MoreDaVita Giving Foundation Invests $1 Million in Western Governors University to Support Nursing Students

World Courier to Expand Storage Capacity and Cold Chain Capabilities With Three New Transport Stations in the United States

World Courier, a global specialty logistics provider and a part of Cencora (formerly AmerisourceBergen), will open transport stations in three new markets in the United States, expanding its presence and capacity to deliver specialized logistics support as the specialty pharmaceutical market continues…

Read MoreWorld Courier to Expand Storage Capacity and Cold Chain Capabilities With Three New Transport Stations in the United States

Thubrikar Aortic Valve Announces Authorization to Expand the TAVI-1 CE Mark Trial with the Precision 2™ Delivery Catheter

-Thubrikar Aortic Valve, Inc. today announced authorization from the Competent Authority of Poland to expand the TAVI-1 CE Mark trial of the Optimum Transcatheter Aortic Valve Implantation System™ (Optimum TAVI System™). The authorization allows for an additional 15 patients to…

Read MoreThubrikar Aortic Valve Announces Authorization to Expand the TAVI-1 CE Mark Trial with the Precision 2™ Delivery Catheter